Candel Therapeutics Inc (CADL)
5.19
+1.87%
Candel Therapeutics Inc (CADL) is currently trading at $5.19. This represents a gain of 1.87% from the previous session. With a market capitalization of $0.38B, CADL is a key component of the Health Care sector. Investors looking to trade CADL should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade CADL commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Candel Therapeutics Inc (CADL) shows a bullish trend. Analysts are watching the 5.20 level closely.
Fundamentals
Mkt Cap0.38B
P/E Ratio0.0000
Volume682,829
60-Day Technical Chart
Advanced Charting
Need more indicators for CADL? Use the world's #1 platform.
Open CADL on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $5
| Metric |
CADL +1.87% |
OPEN -3.52% |
NIO -0.85% |
SNAP +1.41% |
|---|---|---|---|---|
| Price | $5.19 | $4.95 | $5.26 | $5.04 |
| Mkt Cap | $0.38B | $4.74B | $12.85B | $8.51B |
| - | View → | View → | View → |
Latest Headlines
Cancer biotech Candel prices $100M sale to back prostate launch prep, lung trial
Stock Titan • Feb 20, 2026
Cancer-drug maker Candel plans $100M sale for prostate, lung push
Stock Titan • Feb 19, 2026
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
GlobeNewswire • Feb 11, 2026
Candel Therapeutics: Potentially The Next Exciting Oncology Story
Seeking Alpha • Sep 7, 2025
$CADL stock is down 9% today. Here's what we see in our data.
Quiver Quantitative • Oct 14, 2025
● Gemini Agentic AI Analyst Insight for CADL
Market Education
- I don't get this Dollar Cost Averaging (DCA). Explain pls Jul 18, 2023
- The Basics of the Stock Market for Beginners Aug 25, 2023
- AI and the Stock Market: How Artificial Intelligence Is Driving a New Bull Run Sep 26, 2025
External Research